What is the management plan for cholangitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management Plan for Cholangitis - Full SOAP

SUBJECTIVE

Key Clinical Features to Assess:

  • Classic Charcot's Triad (present in minority of cases): fever, jaundice, right upper quadrant pain 1
  • Reynolds Pentad (severe disease): Charcot's triad plus altered mental status and hypotension 1
  • Alarm symptoms: fever, abdominal pain, distention, jaundice, nausea, vomiting 2
  • Risk factors: recent biliary instrumentation, choledocholithiasis, biliary strictures, malignancy, prior biliary surgery 3
  • Comorbidities: assess for immunosuppression, cirrhosis, portal hypertension, underlying malignancy 4

OBJECTIVE

Laboratory Assessment:

  • Liver function tests: direct and indirect bilirubin, AST, ALT, ALP, GGT, albumin 2
  • Inflammatory markers: CRP, procalcitonin, lactate (for severity assessment and monitoring) 2
  • Blood cultures: obtain before antibiotics in stable patients; do not delay antibiotics >1 hour in severe sepsis/shock 2
  • Bile cultures: obtain at time of drainage procedure 5

Imaging Studies:

  • First-line: Abdominal triphasic CT to detect intra-abdominal fluid collections and ductal dilation 2
  • Complementary: MRCP for exact visualization, localization, and classification of biliary obstruction 2, 5
  • Dynamic liver MRI or contrast CT: for new/changing symptoms or evolving laboratory abnormalities 2

Severity Grading:

Apply Tokyo Guidelines criteria to classify as Grade I (mild), Grade II (moderate), or Grade III (severe) to guide timing of intervention 5

ASSESSMENT

Diagnosis Confirmation:

Acute cholangitis with severity classification based on clinical presentation, laboratory findings, and imaging demonstrating biliary obstruction with infection 5

Differential Considerations:

Rule out cholecystitis, hepatic abscess, malignant obstruction, primary sclerosing cholangitis with dominant stricture 2

PLAN

1. Immediate Resuscitation and Antibiotic Therapy

Antibiotic Administration (Critical Priority):

  • Timing: Within 1 hour for septic shock; within 4 hours for all other cases 5
  • In patients without shock: May obtain radiological/bacteriological sampling with up to 6-hour delay before antibiotics 2
  • In severe sepsis/shock: Substantially shorten investigation window, start broad-spectrum antibiotics within 1 hour 2

Antibiotic Regimen:

Broad-spectrum options (choose one) 2, 5:

  • Piperacillin/tazobactam
  • 4th-generation cephalosporin
  • Imipenem/cilastatin
  • Meropenem
  • Ertapenem
  • Aztreonam

Additional coverage:

  • Add amikacin in cases of associated shock 2
  • Add fluconazole in fragile patients or delayed diagnosis 2, 5
  • Tailor antibiotics to bile and blood culture results once available 2

Antibiotic Duration:

  • Standard duration: 3-5 days after successful biliary drainage 5, 6
  • Short duration (4 days) is noninferior to conventional duration (8 days) for moderate-to-severe cholangitis 6
  • Extended duration (2 weeks): For Enterococcus or Streptococcus to prevent infectious endocarditis 2
  • Longer courses: Consider in cases of residual stones or ongoing obstruction 5

2. Biliary Decompression (Definitive Treatment)

ERCP is the first-line treatment for biliary decompression 2, 5

Timing of Intervention:

  • Severe cholangitis (Grade III): Urgent ERCP with biliary drainage 5
  • Moderate cholangitis (Grade II): Early decompression within 24 hours 5
  • Mild cholangitis (Grade I): May tolerate delayed approach if responding to antibiotics, typically within 72 hours 4

Endoscopic Options:

  • Nasobiliary drain placement with endoscopic sphincterotomy 2, 5
  • Biliary stent placement (equally effective as nasobiliary drain; associated with less post-procedure discomfort) 2
  • Endoscopic sphincterotomy with stone extraction (preferred in patients responding to antibiotics) 3
  • Stent placement with or without sphincterotomy (safest option in ongoing sepsis with multiple large stones) 3

Prophylactic Antibiotics for ERCP:

Administer prophylactic antibiotics before ERCP, especially when incomplete drainage is anticipated 2

3. Alternative Drainage Approaches

Percutaneous Transhepatic Biliary Drainage (PTBD):

Reserve PTBD for patients in whom ERCP fails or is not feasible (unsuccessful biliary cannulation, inaccessible papilla) 2, 5

  • PTBD carries higher complication risks including biliary peritonitis, hemobilia, pneumothorax, hematoma, liver abscesses 2

Open Surgical Drainage:

Use only when endoscopic or percutaneous approaches are contraindicated or unsuccessful 2, 5

  • Emergency surgery for severe cholangitis carries high mortality rates 2
  • Endoscopic drainage is preferred given shorter hospitalization and fewer serious complications 2

4. Supportive Care

  • Fluid resuscitation: Aggressive IV hydration 3, 4
  • Correction of coagulopathy 3
  • ICU admission: For severe cholangitis with septic shock or organ dysfunction 5
  • Vasopressor support: As needed for hemodynamic instability 4

5. Monitoring and Follow-up

  • Monitor bilirubin levels to assess response to treatment 5
  • Clinical reassessment: Evaluate for fever resolution, improvement in mental status, hemodynamic stability 4
  • Repeat imaging: If no clinical improvement or worsening despite treatment 2
  • Evaluate for definitive treatment of underlying cause (cholecystectomy for choledocholithiasis, evaluation for malignancy) 3

6. Special Considerations

Recurrent Cholangitis:

  • Long-term prophylactic antibiotics: Consider in patients with compromised biliary systems (endoprosthesis, hepaticojejunostomy) 7
  • Liver transplantation evaluation: For patients with recurrent cholangitis 5

Dominant Strictures in PSC:

  • Endoscopic dilatation with or without stenting 5
  • Brush cytology and/or endoscopic biopsy: Perform to exclude malignancy prior to therapy 5

Post-operative Cholangitis:

  • Localized abscesses: Antibiotics and/or percutaneous drainage when no generalized peritonitis 2
  • Generalized peritonitis: Prompt surgical source control 2

COMMON PITFALLS TO AVOID

  • Delaying antibiotic administration in severe cases increases mortality; start within 1 hour for septic shock 5
  • Failure to achieve adequate biliary drainage is associated with poor outcomes 5
  • Overlooking fungal infection in patients not responding to antibiotic therapy 5
  • Underestimating need for ICU admission in severe cholangitis 5
  • Performing ERCP without expert multidisciplinary assessment in complex cases 2
  • Unnecessarily prolonged antibiotic courses when adequate drainage achieved 6

References

Research

The Emergency Medicine-Focused Review of Cholangitis.

The Journal of emergency medicine, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of cholangitis.

Journal of hepato-biliary-pancreatic surgery, 2003

Research

Acute cholangitis.

Frontiers in bioscience : a journal and virtual library, 2003

Guideline

Management of Hyperbilirubinemia in Acute Cholangitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.